CMPX Compass Therapeutics, Inc.
Healthcare$2.07+7.25%ClosedMarket Cap: $286.3M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$11.20
Target (Median)
$10.00
Target Range
$9.00 - $15.00
Upside from current price: 441.1%
Rating Distribution
2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-28 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-04-28 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-04-27 | D. Boral Capital | maintain | Buy | Buy |
| 2026-04-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-24 | Guggenheim | maintain | Buy | Buy |
| 2026-01-06 | D. Boral Capital | maintain | Buy | Buy |
| 2025-11-05 | D. Boral Capital | maintain | Buy | Buy |
| 2025-08-12 | D. Boral Capital | maintain | Buy | Buy |
| 2025-08-12 | Guggenheim | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.46 | $25.9M | 11 |
| Sun Dec 31 | $-0.14 | $126.9M | 12 |
| Mon Dec 31 | $0.30 | $264.3M | 10 |
| Tue Dec 31 | $0.66 | $378.0M | 5 |